BIWH-3 (Boehringer Ingelheim)

N/A

Report date: 2026/03/23 20:03:44

Base Information

Drug NameBIWH-3 (Boehringer Ingelheim)
Drug Alias Namepyro-Glu-rhMCP-1MCP-1 - Boehringer IngelheimBIWH-3
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionC-C motif chemokine 2 modulators
TargetsC-C motif chemokine 2
Therapy Area/IndicationsPeripheral Arterial Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. Kg
Active IndicationsN/A
Inactive IndicationsPeripheral Arterial Disease

Other Information

ATC CodeN/A
Related LinksN/A